oral lichen planus, oral lichenoid lesions, statin, levothyroxine, hypertension, hyperlipidemia


BACKGROUND: The investigators aim to determine the frequency of systemic medications in patients with oral lichen planus or oral lichenoid lesions. METHODS: A retrospective study of lichenoid diagnoses in the New York University College of Dentistry Oral Medicine Clinic. Data obtained included patient demographics, prescription medications and pathologic diagnosis. Comparative analysis was performed. RESULTS: A total of 162 oral lichenoid lesion/oral lichen planus patients were identified: The most frequently found medications were anti-hypertensives, anti-hyperlipidemics followed by metformin, proton pump inhibitors and levothyroxine. CONCLUSION: The findings emphasize the importance of clinicians’ awareness of potential oral adverse reactions from certain medications.